Alumis Inc. is a precision medicines company with the mission to transform the lives of patients with autoimmune diseases. Even with treatment innovations of the last two decades, many patients with immunologic conditions continue to suffer - our goal is to fundamentally change the outcomes for these patients.
We are seeking an experienced Senior Manager, FP&A – Clinical & Development to join our team in a fast-paced, high-growth environment. This position will serve as a strategic business partner to the Clinical and Development organization, supporting a growing portfolio of clinical studies and development candidates. In this role, you will play a critical part in managing planning processes, partnering closely with Clinical Development leadership, and assisting the Sr. Director of FP&A in overall planning strategy and execution. This position will also involve close interaction with the accounting team during month-end close processes.
Responsibilities
- Partner closely within Clinical and Development team to provide effective planning and analysis; provide senior leadership & business partners with appropriate tools and analysis to establish goal and measure performance.
- Attend program team and development leadership meetings.
- Responsible for financial reporting, including monthly comparison of actual vs. budget results and relevant variance analysis, in a timely and accurate manner.
- Collaborate with the Accounting team on monthly close to ensure accruals and expenses are recorded accurately and promptly.
- Assist Sr. Director, FP&A in the management of the LRP and budget processes, support compliance of internal controls, preparation of finance materials for the Board, and other high priority projects.
- Strong interpersonal skills to collaborate, influence, build credibility with business partners across the organization & especially with Clinical and Development team.
- Educate project team leads and functional heads about the budgeting process and the importance of their role in a successful process.
Qualifications
- Bachelor’s in Finance, Accounting or relevant degree.
- 7+ years of progressive financial reporting, planning and analysis experience in the pharmaceutical or biotechnology industry.
- Prior experience supporting R&D organizations and/or teams is highly preferred.
- System savvy, ideally with experience implementing or overseeing financial planning and reporting tools. Experience with Adaptive Insights is a plus.
- Strong and advanced Excel modeling and analytical skills as well as solid accounting knowledge.
- Strong written, verbal, and interpersonal skills.
The salary range for this position is $160,000 USD to $200,000 USD annually. This salary range is an estimate, and the actual salary may vary based on the Company’s compensation practices.
This position is located in South San Francisco, CA, with an expectation to be onsite Tuesday through Thursday.
Alumis Inc. is an equal opportunity employer.
Alumis compensation packages include generous stock option grants for all employees as well as an annual bonus program.
Other benefits include:
- Health insurance premiums paid at 90% for employee, 80% for dependents
- Free access to Genentech Bus & Ferry Share program
- $100 monthly cell phone stipend
- Unlimited PTO for Exempt employees
- Free onsite gym and a kitchen stocked with yummy snacks and drinks!
We are a hard-working, collaborative team on a mission to transform patient’s lives-- and we aspire to elevate, challenge and nurture one another along the way.
Similar Jobs
What We Do
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.
We recognize that patients living with immune-mediated diseases need alternatives to currently available therapies. Despite recent advances and innovations in the treatment of immune-mediated diseases, many patients continue to suffer, cycling through currently approved therapies while looking for a solution that alleviates the debilitating impact of their disease without life-limiting side effects.
Addressing the needs of these patients is why we exist. We are pioneering a precision approach that leverages insights we derive from powerful data analytics to select the right target, right molecule, right indication, right patient, and right endpoint resulting in optimized outcomes for patients. We believe that combining our insights with an integrated approach to drug development will produce the next generation of treatments to address immune dysfunction.
Incubated by Foresite Labs, Alumis is led by a team of deeply experienced professionals who are devoted to transforming the lives of patients with immune-mediated diseases by developing a pipeline of transformative therapies.
